Skip to main content

Nearly matured medical marijuana plants grow in a climate controlled growing room.James MacDonald/Bloomberg

Our roundup of Canadian small-caps of between $100-million and $2.5-billion in market capitalization making news and on the move today.

Canopy Growth Corp. (WEED-T) announced an update on its expansion in Canada including:

• An agreement with Goldman Holdings, Ltd. to begin build-out and licensing process for a 160,000-square-foot indoor facility in Edmonton.

• An agreement to buy a 100,000 square-foot facility in Fredericton, "with the intention of launching a Tweed facility for indoor production in New Brunswick."

• Expansion of its flagship facility in Smiths Falls, Ont. to include 33-per-cent more flowering space.

• Retrofit and expansion at the Mettrum Bowmanville, Ont.-facility completed and licensed, adding 200 per cent more production capacity.

• Received its cultivation license at the Yorkton, Sask.-based Tweed Grasslands facility.

"Our ongoing mission is to build the brands and products that people want, and to support those brands with the necessary capacity footprint to satisfy all the customers who trust our family of companies for their cannabis," the company stated in a release.

It reports its fourth-quarter and fiscal year results on Tuesday.


Altius Minerals Corp. (ALS-T) says its subsidiary Altius Resources Inc has acquired 980,000 common shares of Antler Gold Inc. (ANTL-T).

It said the purchase is "as consideration for the grant by Altius Resources of an option to earn a 100-per-cent interest in certain mineral claims located near Wilding Lake in the Central Newfoundland area of Newfoundland and Labrador."

Altius Resources now owns 5.5 million shares or about 19.9 per cent of the company.


Home Capital Group Inc. (HCG-T) reported its financial position as of June 22.

Its total credit capacity stood at approximately $1.23-billion compared to $1.25-billion on June 21 and $1.06-billion on June 9.

Its Home Trust High-Interest Savings Account deposit balances stood at approximately $112.1-million, compared to $111.8-million the day before and $105-million on June 9.

Total GICs stood at approximately $12.04-billion compared to $12.03-billion the day before and $12.09 on June 9.


ICC International Cannabis Corp. (ICC-X) promoted Alejandro Antalich to CEO and Diego Taranto to senior financial controller.

"These management changes come at a time when the company is transitioning from an early stage licensed producer to a fully licensed producer and distributor of recreational cannabis in Uruguay," it said in a release.

It said CEO Guillermo Delmonte has stepped down effective today "and will assist Mr. Antalich in the transition of responsibilities."

Mr. Antalich joined ICC in March 2017 as senior operations manager and has more than 25 years of experience in the healthcare and pharmaceutical industry in Uruguay.

His appointment as CEO is subject to TSX Venture Exchange approval, the company said.


CRH Medical Corp. (CRH-T; CRHM-N) has increased its credit facility with a syndicate of lenders led by the Bank of Nova Scotia to $100-million (U.S.) from $50-million.

It said the new facility now includes a $75-million revolving credit facility and a $25-million term facility. CRH said it has access to an uncommitted accordion facility that would increase revolving credit facilities available by $25-million.

It said the new facilities will be used to fund future acquisitions and to repay debt owing to Crown Capital Fund III Management Inc. provided in December 2014.

It also reduces the interest rate and the standby fees payable by CRH.


Anglo Pacific Group PLC (APF-L; APY-T), which trades in Toronto and London, declared an interim dividend for 2017 of 3 pence per share.

"This will be the first dividend paid under the company's new dividend payment schedule, which will accelerate the payment of dividends by 85 days," the company said.

"Following the payment of the interim dividend on November 15, 2017 the company will commence paying its dividend on a quarterly

Report an error

Editorial code of conduct